Changing to reach and frequency in a division where that does not work (Rare Disease). Products are great, but all new upper management will have patients switch to competitors. Rare is not big pharma.
DMs are puppets without any regard for how their behavior affects employees. No matter how much you give it is never enough and you are treated like gum on the bottom of their shoe. Worst managers on the planet.